Latest Nanomedicine Stories
Sanford-Burnham and Salk Institute scientists combine tumor-targeting peptides and nanoparticles to eliminate glioblastoma in a previously untreatable mouse model Glioblastoma is one of the most aggressive forms of brain cancer. Rather than presenting as a well-defined tumor, glioblastoma will often infiltrate the surrounding brain tissue, making it extremely difficult to treat surgically or with chemotherapy or radiation. Likewise, several mouse models of glioblastoma have proven...
A new review published in WIREs Nanomedicine and Nanobiotechnology explores how nanotechnology may be used to develop safer breast implants as an alternative to silicone rubber, minimizing health complications. Around 75% of post-mastectomy patients elect some form of breast reconstruction. The only material option available to women undergoing breast reconstruction and augmentation is based on silicone rubber. While no medical device is 100% safe and effective, there is an extraordinarily...
TEMPE, Ariz., Sept. 20, 2011 /PRNewswire/ -- Quantum Materials Corporation (www.qdotss.com) (Pink Sheets: QTMM) Quantum Materials Corp. and Nanoaxis, LLC announce the formation of a technology alliance combining Quantum Materials tetrapod quantum dot mass production technology with Nanoaxis advanced research expertise and intellectual property in gene therapy biomedical nanotechnology. The aim of the alliance is to develop Tetrapod Quantum Dot based Cancer diagnostic kits and theranostic...
Ovarian cancer is one of the most frequent forms of cancer that affect women. As tumors can initially grow unchecked in the abdomen without causing any major symptoms, patients are usually diagnosed at an advanced stage and have to undergo surgery plus chemotherapy. During the operation, surgeons attempt to remove all tumor deposits as this leads to improved patient prognosis. To do this, however, they primarily have to rely on visual inspection and palpation - an enormous challenge...
New research opportunities emerge from instrument that immerses researchers in multi-dimensional information What would it be like to dive into the veins and arteries of the human body or weave through the layers of the brain? With the AlloSphere, a 33-foot diameter sphere built inside of a three-story echo-free cube, these feats are now possible. The AlloSphere is one of the largest immersive scientific instruments in the world. It takes scientific data that is too small to see...
Nanobodies produced by camels have unique properties, which can be used in future drug development. New research published in the Journal of Controlled Release confirms that nanobodies can help scientists in the fight against cancer. Members of the camelid family have particular heavy-chain antibodies in their blood known as nanobodies, that may serve as therapeutic proteins. One of the most powerful advantages of nanobodies is that they can be easily attached to other proteins and...
Using ovarian surface epithelial cells from mice, researchers from Virginia Tech have released findings from a study that they believe will help in cancer risk assessment, cancer diagnosis, and treatment efficiency in a technical journal: Nanomedicine http://www.nanomedjournal.com/article/S1549-9634%2811%2900184-5/abstractBy studying the viscoelastic properties of the ovarian cells of mice, they were able to identify differences between early stages of ovarian cancer and more advanced and...
The 2010 Journal Citation Reports® (JCR) shows an impressive improvement in the impact factor for the International Journal of Nanomedicine Providence, RI (PRWEB) June 30, 2011 Thomson Reuters has just released the 2010 Journal Citation Reports® (JCR), showing an impressive improvement to the impact factor for the International Journal of Nanomedicine, published by Dove Medical Press. The 2010 impact factor for the International Journal of Nanomedicine has been released at...
(Ivanhoe Newswire) "“ A novel discovery disguising nanoparticles as red blood cells allows them to invade the body without setting off an immune system response to deliver cancer-fighting drugs straight to the tumor.The method involves collecting the membrane from a red blood cell and wrapping it around a biodegradable polymer nanoparticle stuffed with a cocktail of small molecule drugs."This is the first work that combines the natural cell membrane with a synthetic nanoparticle for drug...
(Ivanhoe Newswire)-- New medical technology is showing that Cornell dots may be a potential cancer diagnostic tool. The U.S Food and Drug Administration (FDA) has recently approved the first clinical trial in humans using Cornell Dots- brightly glowing nanoparticles that can light up cancer cells in PET-optical imaging.Cornell Dots are silica spheres less than eight nanometers in diameter that enclose several dye molecules. To make the dots stick to tumor cells, organic molecules that bind to...
